Aclaris Therapeutics ACRS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.66M-7.3% | -$64.92M+54.2% | -$141.68M-5.2% | -$134.65M-3.4% | -$130.21M+1.4% | ||
| $428K-5.7% | $454K-8.3% | $495K-12.2% | $564K-18.5% | $692K-14.3% | ||
| $12.05M-2.7% | $12.38M+0.5% | $12.32M-1.2% | $12.46M+1.3% | $12.3M+13.3% | ||
| -$52.21M-10.8% | -$47.11M-9.8% | -$42.92M— | —— | —— | ||
| $81K-27.0% | $111K— | —— | —— | —— | ||
| -$1.69M-103% | $48.37M+195% | -$50.73M+17.9% | -$61.76M+8.5% | -$67.48M+3.3% | ||
| $52.19M+990% | -$5.86M-108% | $71.25M-4.1% | $74.32M0.0% | $74.32M-0.3% | ||
| —— | —— | —— | —— | -$5.48M+64.2% | ||
| -$52.29M-10.7% | -$47.22M-9.8% | -$43.01M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aclaris Therapeutics generate?
- Aclaris Therapeutics (ACRS) generated -$52.2M in operating cash flow over the trailing twelve months.
- What is Aclaris Therapeutics's free cash flow?
- After $81.0K of capital expenditures, Aclaris Therapeutics's free cash flow was -$52.3M over the trailing twelve months, up 5.4% year over year.
- Where does Aclaris Therapeutics's cash flow data come from?
- Every line is extracted from Aclaris Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
